共 88 条
[1]
Verschuuren JJ(2022)Advances and ongoing research in the treatment of autoimmune neuromuscular junction disorders Lancet Neurol 21 189-202
[2]
Palace J(2022)Epidemiology, diagnostics, and biomarkers of autoimmune neuromuscular junction disorders Lancet Neurol 21 176-188
[3]
Murai H(2020)Mortality rates and causes of death in Swedish Myasthenia Gravis patients Neuromuscul Disord 30 815-824
[4]
Tannemaat MR(2022)Drug-refractory myasthenia gravis: Clinical characteristics, treatments, and outcome Ann Clin Transl Neurol 9 122-131
[5]
Kaminski HJ(2000)Myasthenia gravis: recommendations for clinical research standards Neurology 55 16-23
[6]
Bril V(2012)Antibodies identified by cell-based assays in myasthenia gravis and associated diseases Ann NY Acad Sci 1274 92-98
[7]
Punga AR(2011)Diagnostic utility of stimulated single-fiber electromyography of the orbicularis oculi muscle in patients with suspected ocular myasthenia Muscle Nerve 43 168-170
[8]
Maddison P(2021)The Duke myasthenia gravis clinic registry: I. Description and demographics Muscle Nerve 63 209-216
[9]
Heckmann JM(2020)Controversies in Ocular Myasthenia Gravis Front Neurol 269 3050-2364
[10]
Guptill JT(2021)Burden of disease in myasthenia gravis: taking the patient’s perspective J Neurol 89 2357-e1628